Literature DB >> 16621993

CXCR5/CXCL13 interaction is important for double-negative regulatory T cell homing to cardiac allografts.

Boris P-L Lee1, Wenhao Chen, Hui Shi, Sandy D Der, Reinhold Förster, Li Zhang.   

Abstract

Accumulating evidence indicates that regulatory T (Treg) cells control development of various diseases both systemically and locally. However, molecular mechanisms involved in Treg cell homing remain elusive. We have shown previously that alphabetaTCR(+)CD3(+)CD4(-)CD8(-) double-negative (DN) Treg cells selectively accumulate in tolerant allografts to maintain localized immune regulation. However, the molecular mechanism leading to the accumulation of DN Treg cells in tolerant grafts was not known. Our cDNA microarray analysis revealed significant up-regulation of chemokine receptor CXCR5 mRNA in DN Treg clones compared with nonregulatory clones. In this study, we examined the importance of CXCR5 in mediating DN Treg migration. Compared with CD4 and CD8 T cells, both primary DN Treg cells and clones constitutively express high levels of CXCR5 protein, enabling them to migrate toward increasing CXCL13 gradients in vitro. After infusion into recipient mice, CXCR5(+) DN Treg clones, but not their CXCR5(-) mutants, preferentially accumulated in cardiac allografts and could prevent graft rejection. Furthermore, we found that allogeneic cardiac allografts express high levels of CXCL13 mRNA compared with either recipient native hearts or nontransplanted donor hearts. Ab neutralization of CXCL13 abrogated DN Treg cell migration in vitro and prevented in vivo homing of DN Treg clones into allografts. These data demonstrate that DN Treg cells preferentially express CXCR5, and interaction of this chemokine receptor with its ligand CXCL13 plays an important role in DN Treg cell migration both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621993     DOI: 10.4049/jimmunol.176.9.5276

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Double-negative regulatory T cells: non-conventional regulators.

Authors:  Christopher W Thomson; Boris P-L Lee; Li Zhang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.

Authors:  Xiaowei Chen; Yoshihiro Takemoto; Huan Deng; Moritz Middelhoff; Richard A Friedman; Timothy H Chu; Michael J Churchill; Yan Ma; Karan K Nagar; Yagnesh H Tailor; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

Review 3.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

4.  CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis.

Authors:  Jill M Kramer; Ekaterina Klimatcheva; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

5.  B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model.

Authors:  Yigeng Cao; Xiaoyi Qin; Na Wang; Erlie Jiang; Mingzhe Han; Yongyong Ma; Bin Liang; Kaiyan Yang; Kang Yu; Haige Ye
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

6.  CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.

Authors:  Robert J MacDonald; Andrew Yen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-10-01       Impact factor: 2.416

7.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

8.  Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.

Authors:  Bartosz Bielecki; Andzelika Mazurek; Paweł Wolinski; Andrzej Glabinski
Journal:  J Clin Immunol       Date:  2007-10-25       Impact factor: 8.317

9.  A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation.

Authors:  Chia-Ling Nhan-Chang; Roberto Romero; Juan Pedro Kusanovic; Francesca Gotsch; Samuel S Edwin; Offer Erez; Pooja Mittal; Chong Jai Kim; Mi Jeong Kim; Jimmy Espinoza; Lara A Friel; Edi Vaisbuch; Nandor Gabor Than; Shali Mazaki-Tovi; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-11

10.  Changes in gene expression of pial vessels of the blood brain barrier during murine neurocysticercosis.

Authors:  Pramod Kumar Mishra; Judy M Teale
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.